Table of Contents

company-logo

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Harrow Health Dividend Announcement

• Harrow Health does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Harrow Health dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Harrow Health Dividend History

Harrow Health Dividend Yield

Harrow Health current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Harrow Health stock? Use our calculator to estimate your expected dividend yield:

Harrow Health Financial Ratios

P/E ratio-44.95
PEG ratio19.80
P/B ratio25.90
ROE-54.11%
Payout ratio0.00%
Current ratio1.55
Quick ratio1.44
Cash Ratio0.76

Harrow Health Dividend FAQ

Does Harrow Health stock pay dividends?
Harrow Health does not currently pay dividends to its shareholders.
Has Harrow Health ever paid a dividend?
No, Harrow Health has no a history of paying dividends to its shareholders. Harrow Health is not known for its dividend payments.
Why doesn't Harrow Health pay dividends?
There are several potential reasons why Harrow Health would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Harrow Health ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Harrow Health has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Harrow Health a dividend aristocrat?
Harrow Health is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Harrow Health a dividend king?
Harrow Health is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Harrow Health a dividend stock?
No, Harrow Health is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Harrow Health stocks?
To buy Harrow Health you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Harrow Health stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.